Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

L Latorre

Showing results (21-30 of 22) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 22 results.
Mucosal Immunology|July 11, 2018
The JAK inhibitor ruxolitinib reduces inflammation in an ILC3-independent model of innate immune colitisA M Overstreet, D L LaTorre, L Abernathy-Close, et al.
Communicable Diseases Intelligence Quarterly Report|June 5, 2010
Surveillance of antibiotic resistance in Neisseria gonorrhoeae in the WHO Western Pacific and South East Asian regions, 2007-2008, , J W Tapsall, et al.
Pageof 3

Showing results (21-30 of 22) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 22 results.
Mucosal Immunology|July 11, 2018
The JAK inhibitor ruxolitinib reduces inflammation in an ILC3-independent model of innate immune colitisA M Overstreet, D L LaTorre, L Abernathy-Close, et al.
Communicable Diseases Intelligence Quarterly Report|June 5, 2010
Surveillance of antibiotic resistance in Neisseria gonorrhoeae in the WHO Western Pacific and South East Asian regions, 2007-2008, , J W Tapsall, et al.
Pageof 3